Shares of Natco Pharma gained over 3% in a weak market today after the company received a favourable judgement from Delhi High Court in a patent infringement case of Chlorantraniliprole (CTPR) process. Natco Pharma stock rose 3.51% to Rs 599.05 today against the previous close of Rs 578.75 on BSE.